Blog
RSS FeedPosted by Michael Wonder on 08 Nov 2025
Novo Nordisk announces agreement with the US Administration to bring GLP-1s to more Americans at a lower cost
6 November 2025 - Today it was announced that Novo Nordisk has agreed with the US Administration to lower drug prices ...
Posted by Michael Wonder on 07 Nov 2025
CMS announces new drug payment model to strengthen Medicaid and better serve vulnerable Americans
6 November 2025 - The CMS is tackling high drug prices and protecting the American taxpayers through a landmark Innovation Center ...
Posted by Michael Wonder on 23 Oct 2025
New ICER report shows significant jump in launch prices, exceeding inflation and GDP growth
23 October 2025 - Nearly $1.5 billion could have been saved in one year alone if prices matched ICER value ...
Posted by Michael Wonder on 17 Oct 2025
Merck announces unprecedented agreement with US Government to expand access to IVF therapies
16 October 2025 - Merck announced today that EMD Serono, the healthcare business of Merck in the US and Canada, ...
Posted by Michael Wonder on 10 Oct 2025
AstraZeneca announces historic agreement with US Government to lower the cost of medicines for American patients
10 October 2025 - AstraZeneca today announces a historic agreement with President Donald J. Trump’s administration to lower the cost ...
Posted by Michael Wonder on 09 Oct 2025
Donald Trump’s cure for drug prices is worse than the disease
2 October 2025 - Few things infuriate Americans as much as drug prices. Republicans and Democrats alike agree that poorly patients ...
Posted by Michael Wonder on 06 Oct 2025
Amgen makes Repatha available though AmgenNow, a direct to patient program in the US
6 October 2025 - Eligible patients can access Repatha at nearly 60% discount from the list price. ...
Posted by Michael Wonder on 05 Oct 2025
Why Pfizer’s Trump deal is good news for all of big pharma
2 October 2025 - The company’s accord with the president clears a cloud over the whole sector. ...
Posted by Michael Wonder on 04 Oct 2025
Does big pharma gouge Americans?
2 October 2025 - In the bloated health care system, others are the real money makers. ...
Posted by Michael Wonder on 03 Oct 2025
Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride) in the UK at a list price equal to the US launch price
22 September 2025 - Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride), in the UK in 2026. ...
Posted by Michael Wonder on 01 Oct 2025
White House unveils ‘TrumpRx’ drug buying site and a Pfizer pricing deal
30 September 2025 - The company says it gains a three year grace period to exempt it from national-security-related tariffs. ...
Posted by Michael Wonder on 30 Sep 2025
Pfizer reaches landmark agreement with US Government to lower drug costs for American patients
30 September 2025 - Voluntary agreement meets the President’s four requests while also protecting the US ecosystem responsible for America’s leadership ...
Posted by Michael Wonder on 29 Sep 2025
AbbVie announces UK pricing strategy for Elahere (mirvetuximab soravtansine-gynx)
29 September 2025 - The list price will be consistent with the US to reflect the value of the innovation. ...
Posted by Michael Wonder on 28 Sep 2025
Donald Trump is waging war on sky-high drug prices. Can he win?
28 September 2025 - Big Pharma has a big headache: Donald Trump. Lately drugmakers have had to contend with the ...
Posted by Michael Wonder on 15 Sep 2025
ICER to undertake special report on Crohn’s disease and ulcerative colitis for CMS as part of public comment process on Medicare drug price negotiations
15 September 2025 - Report to reflect legislative specifications in the Inflation Reduction Act and most recent CMS guidance regarding ...